Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Yu

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|October 18, 2021
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trialJessica M Scott, Samantha M Thomas, James E Herndon, et al.
JACC. Cardiooncology|June 19, 2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted TherapyAnthony F Yu, Chau T Dang, Chaya S Moskowitz, et al.
Advances in Radiation Oncology|January 8, 2025
Cardiopulmonary Substructure Doses are Not Correlated With Cardiorespiratory Fitness Among Breast Cancer Survivors Treated With Contemporary Radiation TherapyMaria Thor, Jessica M Scott, Anne S Reiner, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Physics and Imaging in Radiation Oncology|January 23, 2023
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancerJustin M Haseltine, Aditya Apte, Andrew Jackson, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
The Journal of Experimental Medicine|December 19, 2022
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapiesAchraf Shamseddine, Suchit H Patel, Valery Chavez, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
European Heart Journal|February 22, 2023
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trialJessica M Scott, Jasme Lee, James E Herndon, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Cachexia, Sarcopenia and Muscle|October 18, 2021
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trialJessica M Scott, Samantha M Thomas, James E Herndon, et al.
JACC. Cardiooncology|June 19, 2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted TherapyAnthony F Yu, Chau T Dang, Chaya S Moskowitz, et al.
Advances in Radiation Oncology|January 8, 2025
Cardiopulmonary Substructure Doses are Not Correlated With Cardiorespiratory Fitness Among Breast Cancer Survivors Treated With Contemporary Radiation TherapyMaria Thor, Jessica M Scott, Anne S Reiner, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Physics and Imaging in Radiation Oncology|January 23, 2023
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancerJustin M Haseltine, Aditya Apte, Andrew Jackson, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
The Journal of Experimental Medicine|December 19, 2022
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapiesAchraf Shamseddine, Suchit H Patel, Valery Chavez, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
European Heart Journal|February 22, 2023
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trialJessica M Scott, Jasme Lee, James E Herndon, et al.
Pageof 7